Global Embolic Protection Device Market is forecasted to be US$ 713.6 Million by 2027, this growth is due to rise in the elderly population and cardiovascular cases etc.
07 Feb, 2023

According to Renub Research's latest report, "Global Embolic Protection Device Market, Size, forecast 2022-2027, Industry Trends, Share, Growth, Company Analysis," Global Embolic Protection Device Market is estimated to reach US$ 713.6 Million by 2027. Embolic Protection Devices are catheter-based devices that are used to capture atherothrombotic debris that is released during percutaneous vascular interventions. The embolic protection device is used to treat coronary saphenous vein bypass grafts, perform carotid arterial stenting, and treat acute coronary syndromes. The requirement for various surgical and non-surgical therapies is rising due to the increased prevalence of cardiovascular illnesses. According to the AHA (American Heart Association), over 92 Million Americans have some form of cardiovascular disease, and every day, 2,300 people in the country die from the disease. 

Global Embolic Protection Device Market will grow at a CAGR of 7.98% during the forecast period 2022-2028:

The usage of an embolic protection device has helped in the reduction of the number of complications that are caused due to the release of debris in the bloodstream, which results in blockages in small vessels. In addition, the increase in cardiovascular cases, the growing preference for a minimally invasive procedure, and the rise in the elderly population are some factors that add to the growth of the global embolic protection devices market. The World Health Organization estimates that the global geriatric population, between 2015 and 2050, will double from 12% to 22%.

In addition to that, government agencies, non-governmental organizations (NGOs), and educational institutions worldwide are undertaking awareness campaigns to increase knowledge regarding cardiovascular and neurovascular disorders and their available treatment options.

Distal Filter Devices Segment is expected to dominate the Market Share:

The distar filter devices segment's constant growth through the years can be credited to the device's availability of a wide range of specifications and escalating uptake of distal filters, and the usage of distal filters helps in maintaining the flow of blood and traps large debris beneficially in comparison to proximal occlusion systems. 

On the other hand, the proximal occlusion devices are expected to show stable growth during the forecast period. This is because these devices can reduce plaque disruption during embolic protection device implantation. In addition, the device permits stenosis to be crossed while being protected, which enhances its use in various surgical and non-surgical procedures, resulting in market growth for the segment.

Peripheral Vascular Diseases segment is forecasted to grow at an increasing rate in the coming years:

In the U.S., around 12-20% of people aged 60+ years are estimated to suffer from peripheral vascular diseases, according to the Centre for Disease Control and Prevention (CDC). The growing awareness of minimally invasive procedures and increasing cases of lifestyle disorders that lead to different kinds of serious diseases are some of the major contributing factors to the rise of the segment in the market.

Hospital category has dominated the Market Share in the end-user Segment:

The rising incidence of cardiovascular diseases, increasing demand for surgical procedures in hospitals, the availability of skilled and experienced medical personnel, and technologically improved and new medical devices in hospitals are the key reasons for the segment's dominance.

Global Embolic Protection Devices Market was at US$ 486.2 Million in 2022:

Based on geographical regions, the embolic protection market is segmented into Latin America, North America, Europe, Asia-Pacific, the Middle East, and Africa. The Asia Pacifica region is expected to witness lucrative growth during the upcoming years due to increased funding and investments from government and private entities, improved and improvised healthcare infrastructure, and rising disposable income.

However, the North American region has a higher market share, and this can be attributed to the rise in cardiovascular disease (CVD) patients, the presence of R&D facilities in the region, and the quick acceptance of new technology, as well as the high presence of essential market players, is anticipated to propel the growth of the embolic protection devices market in the region.

Competitive Landscape:

The global embolic protection devices market is divided into; Medtronic, Abbott Laboratories, Boston Scientific, Cordis, Silk Road Medical, Abiomed, and Edwards Lifesciences Corporation.

To keep up with the trends of the market and to have a diversified product portfolio, the majority of the above companies have undertaken various market strategies, such as increasing product reliability, investing in research & development activities, and mergers and acquisitions.

Market Summary:

• Market by product in 3 viewpoints (distar filter devices, distar occlusion devices, and proximal occlusion devices).
• Application- The market for Embolic Protection Devices Market breakup up into viewpoints (cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases).
• End-User- Global Embolic Protection Devices Market breakup into two viewpoints (hospitals and ambulatory surgical centers).
• Region- Renub Research report covers by region in 5 viewpoints (North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa).
• Key Players- All the major players have been covered from 4 Viewpoints (Overview, Strategy, Merger/Acquisition, and Financial Insights); Medtronic, Abbott Laboratories, Boston Scientific, Cordis, Silk Road Medical, Abiomed, and Edwards Lifesciences Corporation.